Literature DB >> 25828728

Purity determination of amphotericin B, colistin sulfate and tobramycin sulfate in a hydrophilic suspension by HPLC.

Corina Pfeifer1, Georg Fassauer2, Hagen Gerecke3, Thomas Jira2, Yvonne Remane4, Roberto Frontini4, Jonathan Byrne3, Robert Reinhardt3.   

Abstract

A suspension comprising of the three antibiotic substances amphotericin B, colistin sulfate and tobramycin sulfate is often used in clinical practice for the selective decontamination of the digestive tract of patients in intensive care. Since no detailed procedures, specifications or stability data are available for manufacturing this suspension, there may be discrepancies regarding formulation and stability of suspensions prepared in different pharmacies. The aim of this work is to develop a standardized formulation and to determine its stability under defined storage conditions. This would help guarantee that all patients receive the same preparation, therefore ensuring similar efficacy and improved safety. The first step in this process is to develop the required analytical tools to measure the content and purity of the drug substances in this complex mixture. In this paper, the development and validation of these tools as well as the development of the drug suspension formulation is described. The formulation comprises of Ampho-Moronal(®)-Suspension (Dermapharm) and a buffered, preservated aqueous solution of colistin sulfate and tobramycin sulfate. Two simple, well established high-performance liquid chromatography (HPLC) methods in the European Pharmacopoeia (EP) for impurity profiling of the two active ingredients amphotericin B and colistin sulfate were combined with a newly developed sample extraction procedure for the suspension. Sufficient selectivity and stability-indicating power have been demonstrated. Additionally, a new robust routine method was developed to determine possible degradation products of tobramycin sulfate in the investigated suspension. The specificity, precision, accuracy and linearity of the analytical procedures were demonstrated. The recovery rate was in the range of 90-110%. The precision results for the calculated impurities showed variation coefficients of <10%. The calibration curves were found to be linear with correlation of greater than 0.9994 for all components. The results show the suitability of the methods for the quality control analysis of the suspension.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amphotericin B; Colistin sulfate; ELSD; HPLC; Suspension; Tobramycin sulfate

Mesh:

Substances:

Year:  2015        PMID: 25828728     DOI: 10.1016/j.jchromb.2015.02.043

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  Role of Viscoelasticity in Bacterial Killing by Antimicrobials in Differently Grown Pseudomonas aeruginosa Biofilms.

Authors:  René T Rozenbaum; Henny C van der Mei; Willem Woudstra; Ed D de Jong; Henk J Busscher; Prashant K Sharma
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  A stability study of amphotericin B, colistin and tobramycin in a hydrophilic suspension commonly used for selective decontamination of the digestive tract by HPLC and in vitro potency measurements.

Authors:  Corina Pfeifer; Sylvia Noll; Hagen Gerecke; Georg Fassauer; Thomas Jira; Yvonne Remane; Jan Vogel; Roberto Frontini; Robert Reinhardt
Journal:  Eur J Hosp Pharm       Date:  2016-08-05

Review 3.  An Approach to Measuring Colistin Plasma Levels Regarding the Treatment of Multidrug-Resistant Bacterial Infection.

Authors:  Tatiana Pacheco; Rosa-Helena Bustos; Diana González; Vivian Garzón; Julio-Cesar García; Daniela Ramírez
Journal:  Antibiotics (Basel)       Date:  2019-07-24

Review 4.  Polymyxin Delivery Systems: Recent Advances and Challenges.

Authors:  Natallia V Dubashynskaya; Yury A Skorik
Journal:  Pharmaceuticals (Basel)       Date:  2020-04-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.